• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Cabot Corporation Board Declares Dividend

    1/8/21 5:00:00 PM ET
    $CBT
    Major Chemicals
    Industrials
    Get the next $CBT alert in real time by email

    BOSTON--(BUSINESS WIRE)--On Friday, January 8, 2021, the Board of Directors of Cabot Corporation (NYSE:CBT) declared a quarterly dividend of $0.35 per share on all outstanding shares of the Corporation’s common stock. The dividend is payable on March 12, 2021, to stockholders of record at the close of business on February 26, 2021.

    About Cabot Corporation

    Cabot Corporation (NYSE: CBT) is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company is a leading provider of carbon black, specialty carbons, activated carbon, elastomer composites, inkjet colorants, masterbatches and conductive compounds, fumed silica and aerogel. For more information on Cabot, please visit the company’s website at cabotcorp.com.

    Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: Statements in this press release regarding Cabot's business that are not historical facts are forward looking statements that involve risks and uncertainties. These factors are discussed in the reports we file with the Securities and Exchange Commission (“SEC”), particularly under the heading “Risk Factors” in our annual report on Form 10-K and in our subsequent SEC filings filed with the SEC at www.sec.gov.

    Get the next $CBT alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CBT

    DatePrice TargetRatingAnalyst
    11/11/2024$105.00Neutral → Underweight
    JP Morgan
    4/18/2024Buy → Hold
    Deutsche Bank
    3/27/2024$104.00Buy
    Mizuho
    1/8/2024$90.00 → $87.00Buy → Neutral
    UBS
    6/6/2023$87.00 → $80.00Overweight → Neutral
    JP Morgan
    3/13/2023$94.00Outperform
    Credit Suisse
    11/16/2022$80.00 → $90.00Hold → Buy
    Deutsche Bank
    1/4/2022$75.00 → $70.00Buy
    UBS
    More analyst ratings